RAPGEF3 and cardiac hypertrophy: A dominant negative form of Ras, RasS17N, decreased the effect of Epac1-induced cardiac hypertrophy, highlighting the role of Ras, rather than Rap1, in the β-AR /cAMP/Epac hypertrophic signaling pathway [54].